Subject(s)
Pediatrics , Humans , Child , Pediatrics/standards , Preventive Health Services/standards , United States , Health PolicySubject(s)
Cardiovascular Diseases , Diabetes Complications , Preventive Health Services , Humans , Diabetes Mellitus , Patient Care Management/methods , Patient Care Management/standards , Cardiovascular Diseases/etiology , Cardiovascular Diseases/prevention & control , Preventive Health Services/methods , Preventive Health Services/standards , Diabetes Complications/complications , Diabetes Complications/therapyABSTRACT
Importance: Cervical cancer screening rates are suboptimal in the US. Population-based assessment of reasons for not receiving screening is needed, particularly among women from historically underserved demographic groups. Objective: To estimate changes in US Preventive Service Task Force guideline-concordant cervical cancer screening over time and assess the reasons women do not receive up-to-date screening by sociodemographic factors. Design, Setting, and Participants: This pooled population-based cross-sectional study used data from the US National Health Interview Survey from 2005 and 2019. A total of 20 557 women (weighted, 113.1 million women) aged 21 to 65 years without previous hysterectomy were included. Analyses were conducted from March 30 to August 19, 2021. Exposures: Sociodemographic factors, including age, race and ethnicity, sexual orientation, rurality of residence, and health insurance type. Main Outcomes and Measures: Primary outcomes were US Preventive Services Task Force guideline-concordant cervical cancer screening rates and self-reported primary reasons for not receiving up-to-date screening. For 2005, up-to-date screening was defined as screening every 3 years for women aged 21 to 65 years. For 2019, up-to-date screening was defined as screening every 3 years with a Papanicolaou test alone for women aged 21 to 29 years and screening every 3 years with a Papanicolaou test alone or every 5 years with high-risk human papillomavirus testing or cotesting for women aged 30 to 65 years. Population estimation included sampling weights. Results: Among 20â¯557 women (weighted, 113.1 million women) included in the study, most were aged 30 to 65 years (16 219 women; weighted, 86.3 million women [76.3%]) and had private insurance (13 571 women; weighted, 75.8 million women [67.0%]). With regard to race and ethnicity, 997 women (weighted, 6.9 million women [6.1%]) were Asian, 3821 women (weighted, 19.5 million women [17.2%]) were Hispanic, 2862 women (weighted, 14.8 million women [13.1%]) were non-Hispanic Black, 12 423 women (weighted, 69.0 million women [61.0%]) were non-Hispanic White, and 453 women (weighted, 3.0 million women [2.7%]) were of other races and/or ethnicities (including Alaska Native and American Indian [weighted, 955 000 women (0.8%)] and other single and multiple races or ethnicities [weighted, 2.0 million women (1.8%)]). In 2019, women aged 21 to 29 years had a significantly higher rate of overdue screening (29.1%) vs women aged 30 to 65 years (21.1%; P < .001). In both age groups, the proportion of women without up-to-date screening increased significantly from 2005 to 2019 (from 14.4% to 23.0%; P < .001). Significantly higher rates of overdue screening were found among those of Asian vs non-Hispanic White race and ethnicity (31.4% vs 20.1%; P = .01), those identifying as LGBQ+ (gender identity was not assessed because of a small sample) vs heterosexual (32.0% vs 22.2%; P < .001), those living in rural vs urban areas (26.2% vs 22.6%; P = .04), and those without insurance vs those with private insurance (41.7% vs 18.1%; P < .001). The most common reason for not receiving timely screening across all groups was lack of knowledge, ranging from 47.2% of women identifying as LGBQ+ to 64.4% of women with Hispanic ethnicity. Previous receipt of a human papillomavirus vaccine was not a primary reason for not having up-to-date screening (<1% of responses). From 2005 to 2019, among women aged 30 to 65 years, lack of access decreased significantly as a primary reason for not receiving screening (from 21.8% to 9.7%), whereas lack of knowledge (from 45.2% to 54.8%) and not receiving recommendations from health care professionals (from 5.9% to 12.0%) increased significantly. Conclusions and Relevance: This cross-sectional study found that cervical cancer screening that was concordant with US Preventive Services Task Force guidelines decreased in the US between 2005 and 2019, with lack of knowledge reported as the biggest barrier to receiving timely screening. Campaigns addressing patient knowledge and provider communication may help to improve screening rates, and cultural adaptation of interventions is needed to reduce existing disparities.
Subject(s)
Early Detection of Cancer/statistics & numerical data , Healthcare Disparities/statistics & numerical data , Patient Acceptance of Health Care/statistics & numerical data , Preventive Health Services/statistics & numerical data , Uterine Cervical Neoplasms/prevention & control , Adult , Advisory Committees , Aged , Cross-Sectional Studies , Early Detection of Cancer/standards , Ethnicity/statistics & numerical data , Female , Hispanic or Latino/statistics & numerical data , Humans , Insurance, Health/statistics & numerical data , Middle Aged , Papanicolaou Test , Preventive Health Services/standards , Racial Groups/statistics & numerical data , Rural Population/statistics & numerical data , Sexual Behavior/statistics & numerical data , Surveys and Questionnaires , United States , Young AdultABSTRACT
BACKGROUND: Potentially preventable readmissions of surgical oncology patients offer opportunities to improve quality of care. Identifying and subsequently addressing remediable causes of readmissions may improve patient-centered care. OBJECTIVES: To identify factors associated with potentially preventable readmissions after index cancer operation. METHODS: The New York State hospital discharge database was used to identify patients undergoing common cancer operations via principal diagnosis and procedure codes between the years 2010 and 2014. The 30-day readmissions were identified and risk factors for potentially preventable readmissions were analyzed using competing risk analysis. RESULTS: A total of 53,740 cancer surgeries performed for the following tumor types were analyzed: colorectal (CRC) (42%), kidney (22%), liver (2%), lung (25%), ovary (4%), pancreas (4%), and uterine (1%). The 30-day readmission rate was 11.97%, 47% of which were identified as potentially preventable. The most common cause of potentially preventable readmissions was sepsis (48%). Pancreatic cancer had the highest overall readmission rate (22%) and CRC had the highest percentage of potentially preventable readmissions (51%, hazard ratio [HR] 1.42, 95% confidence interval [95%CI] 1.28-1.61). Risk factors associated with preventable readmissions included discharge disposition to a skilled nursing facility (HR 2.22, 95%CI 1.99-2.48) and the need for home healthcare (HR 1.61, 95%CI 1.48-1.75). CONCLUSIONS: Almost half of the 30-day readmissions were potentially preventable and attributed to high rates of sepsis, surgical site infections, dehydration, and electrolyte disorders. These results can be further validated for identifying broad targets for improvement.
Subject(s)
Aftercare , Dehydration , Neoplasms , Patient Readmission/statistics & numerical data , Preventive Health Services , Surgical Procedures, Operative/adverse effects , Surgical Wound Infection , Water-Electrolyte Imbalance , Aftercare/methods , Aftercare/standards , Aftercare/statistics & numerical data , Dehydration/epidemiology , Dehydration/etiology , Dehydration/prevention & control , Female , Home Care Services/standards , Humans , Male , Middle Aged , Needs Assessment , Neoplasms/classification , Neoplasms/epidemiology , Neoplasms/surgery , New York/epidemiology , Patient Discharge/standards , Preventive Health Services/methods , Preventive Health Services/standards , Quality Improvement , Risk Assessment , Sepsis/epidemiology , Sepsis/etiology , Sepsis/physiopathology , Skilled Nursing Facilities/standards , Surgical Procedures, Operative/methods , Surgical Procedures, Operative/statistics & numerical data , Surgical Wound Infection/epidemiology , Surgical Wound Infection/prevention & control , Water-Electrolyte Imbalance/epidemiology , Water-Electrolyte Imbalance/etiology , Water-Electrolyte Imbalance/prevention & controlABSTRACT
BACKGROUND: In May 2018, the US Preventive Services Task Force (USPSTF) recommended prostate cancer (PCa) screening for ages 55-69 be an individual decision. This changed from the USPSTF's May 2012 recommendation against screening for all ages. The effects of the 2012 and 2018 updates on pathologic outcomes after prostatectomy are unclear. METHODS: This study included 647 patients with PCa who underwent prostatectomy at our institution from 2005 to 2018. Patient groups were those diagnosed before the 2012 update (n = 179), between 2012 and 2018 updates (n = 417), and after the 2018 update (n = 51). We analyzed changes in the age of diagnosis, pathologic Gleason grade group (pGS), pathologic stage, lymphovascular invasion (LVI), and favorable/unfavorable pathology. Multivariable logistic regression adjusting for pre-biopsy covariables (age, prostate-specific antigen [PSA], African American race, family history) assessed impacts of 2012 and 2018 updates on pGS and pathologic stage. A p < 0.05 was statistically significant. RESULTS: Median age increased from 60 to 63 (p = 0.001) between 2012 and 2018 updates and to 64 after the 2018 update. A significant decrease in pGS1, pGS2, pT2, and favorable pathology (p < 0.001), and a significant increase in pGS3, pGS4, pGS5, pT3a, and unfavorable pathology (p < 0.001) was detected between 2012 and 2018 updates. There was no significant change in pT3b or LVI between 2012 and 2018 updates. On multivariable regression, diagnosis between 2012 and 2018 updates was significantly associated with pGS4 or pGS5 and pT3a (p < 0.001). Diagnosis after the 2018 update was significantly associated with pT3a (p = 0.005). Odds of pGS4 or pGS5 were 3.2× higher (p < 0.001) if diagnosed between 2012 and 2018 updates, and 2.3× higher (p = 0.051) if after the 2018 update. Odds of pT3a were 2.4× higher (p < 0.001) if diagnosed between 2012 and 2018 updates and 2.9× higher (p = 0.005) if after the 2018 update. CONCLUSIONS: The 2012 USPSTF guidelines negatively impacted pathologic outcomes after prostatectomy. Patients diagnosed between 2012 and 2018 updates had increased frequency of higher-risk PCa and lower frequency of favorable disease. In addition, data after the 2018 update demonstrate a continued negative impact on postprostatectomy pathology. Thus, further investigation of the long-term effects of the 2018 USPSTF update is warranted.
Subject(s)
Biopsy , Early Detection of Cancer , Practice Guidelines as Topic/standards , Prostate/pathology , Prostatectomy/methods , Prostatic Neoplasms , Age Factors , Biopsy/methods , Biopsy/statistics & numerical data , Early Detection of Cancer/methods , Early Detection of Cancer/standards , Early Detection of Cancer/statistics & numerical data , Humans , Male , Middle Aged , Neoplasm Grading , Neoplasm Staging , Preventive Health Services/methods , Preventive Health Services/standards , Prostatic Neoplasms/epidemiology , Prostatic Neoplasms/pathology , Prostatic Neoplasms/surgery , Risk Assessment , Time , Time-to-Treatment , United States/epidemiologyABSTRACT
Medical consultations before dental procedures present opportunities to integrate cross-disciplinary preventive care and improve patient health. This article presents recommendations related to patients with certain medical conditions who are planning to undergo common dental procedures, such as cleanings, extractions, restorations, endodontic procedures, abscess drainage, and mucosal biopsies. Specifically, prophylactic antibiotics are not recommended for preventing prosthetic joint infections or infectious endocarditis except in certain circumstances. Anticoagulation and antiplatelet therapies typically should not be suspended for common dental treatments. Elective dental care should be avoided for six weeks after myocardial infarction or bare-metal stent placement or for six months after drug-eluting stent placement. It is important that any history of antiresorptive or antiangiogenic therapies be communicated to the dentist. Ascites is not an indication for initiating prophylactic antibiotics before dental treatment, and acetaminophen is the analgesic of choice for patients with liver dysfunction or cirrhosis who abstain from alcohol. Nephrotoxic medications should be avoided in patients with chronic kidney disease, and the consultation should include the patient's glomerular filtration rate. Although patients undergoing chemotherapy may receive routine dental care, it should be postponed when possible in those currently undergoing head and neck radiation therapy. A detailed history of head and neck radiation therapy should be provided to the dentist. Multimodal, nonnarcotic analgesia is recommended for managing acute dental pain.
Subject(s)
Analgesics, Non-Narcotic/therapeutic use , Dentistry , Oral Surgical Procedures , Preventive Health Services , Surgical Clearance/methods , Antibiotic Prophylaxis/methods , Contraindications , Dentistry/methods , Dentistry/standards , Humans , Oral Surgical Procedures/adverse effects , Oral Surgical Procedures/methods , Patient Care Planning/organization & administration , Physical Examination/methods , Preventive Health Services/methods , Preventive Health Services/standardsSubject(s)
Clinical Coding/methods , Crisis Intervention , Suicide, Attempted , Crisis Intervention/methods , Crisis Intervention/statistics & numerical data , Emergency Service, Hospital/organization & administration , England/epidemiology , Humans , Preventive Health Services/methods , Preventive Health Services/standards , Quality Improvement , Suicidal Ideation , Suicide, Attempted/prevention & control , Suicide, Attempted/psychology , Suicide, Attempted/statistics & numerical dataABSTRACT
Clinical preventive service recommendations from the US Preventive Services Task Force (USPSTF) are based on transparent, systematic, and rigorous methods that consider the certainty of the evidence and magnitude of net benefit. These guidelines aim to address the needs of diverse populations. Biological sex and gender identity are sources of diversity that are not often considered in studies of clinical preventive services that inform the recommendations, resulting in challenges when evaluating the evidence and communicating recommendations for persons in specific gender identification categories (man/woman/gender nonbinary/gender nonconforming/transgender). To advance its methods, the USPSTF reviewed its past recommendations that included the use of sex and gender terms, reviewed the approaches of other guideline-making bodies, and pilot tested strategies to address sex and gender diversity. Based on the findings, the USPSTF intends to use an inclusive approach to identify issues related to sex and gender at the start of the guideline development process; assess the applicability, variability, and quality of evidence as a function of sex and gender; ensure clarity in the use of language regarding sex and gender; and identify evidence gaps related to sex and gender. Evidence reviews will identify the limitations of applying findings to diverse groups from underlying studies that used unclear terminology regarding sex and gender. The USPSTF will use gender-neutral language when appropriate to communicate that recommendations are inclusive of people of any gender and will clearly state when recommendations apply to individuals with specific anatomy associated with biological sex (male/female) or to specific categories of gender identity. The USPSTF recognizes limited evidence to inform the preventive care of populations based on gender identity.
Subject(s)
Gender Identity , Preventive Health Services , Sex , Advisory Committees , Evidence-Based Medicine , Female , Humans , Male , Preventive Health Services/standards , Transgender Persons , United StatesABSTRACT
INTRODUCTION: The crisis situation generated by COVID-19 and the measures adopted have generated social changes in the normal dynamics of the general population and especially for health workers, who find themselves caring for patients with suspected or confirmed infection. Recent studies have detected in them depression and anxiety symptoms and burnout syndrome, with personal and social conditions impacting their response capacity during the health emergency. Our aim was to generate recommendations for the promotion and protection of the mental health of health workers and teams in the first line of care in the health emergency due to COVID-19. METHODS: A rapid literature search was carried out in PubMed and Google Scholar, and an iterative expert consensus and through electronic consultation, with 13 participants from the areas of psychology, psychiatry and medicine; the grading of its strength and directionality was carried out according to the international standards of the Joanna Briggs Institute. RESULTS: Thirty-one recommendations were generated on self-care of health workers, community care among health teams, screening for alarm signs in mental health and for health institutions. CONCLUSIONS: The promotion and protection activities in mental health to face the health emergency generated by COVID-19 worldwide can include coordinated actions between workers, health teams and health institutions as part of a comprehensive, community care, co-responsible and sustained over time.
Subject(s)
COVID-19/psychology , Health Personnel/psychology , Mental Disorders/diagnosis , Mental Disorders/therapy , Occupational Diseases/diagnosis , Occupational Diseases/therapy , Occupational Health Services/methods , Humans , Mass Screening/methods , Mass Screening/standards , Mental Disorders/etiology , Mental Disorders/psychology , Occupational Diseases/etiology , Occupational Diseases/psychology , Occupational Health Services/standards , Preventive Health Services/methods , Preventive Health Services/standards , Self Care/methods , Self Care/standardsSubject(s)
Adolescent Health , Advisory Committees , Child Health , Evidence-Based Medicine/methods , Preventive Health Services/methods , Adolescent , Adolescent Health/standards , Advisory Committees/standards , Child , Child Health/standards , Education , Evidence-Based Medicine/standards , Humans , Preventive Health Services/standards , United StatesSubject(s)
Lead Poisoning/diagnosis , Mass Screening/methods , Preventive Health Services/methods , Advisory Committees/standards , Child , Education , Humans , Lead Poisoning/epidemiology , Mass Screening/standards , Preventive Health Services/standards , Risk Assessment/methods , Risk Assessment/standardsSubject(s)
Preventive Health Services , Sexual Behavior , Sexually Transmitted Diseases , Social Determinants of Health , Adolescent , Adolescent Behavior , Adolescent Health/trends , Health Services Needs and Demand , Humans , Preventive Health Services/organization & administration , Preventive Health Services/standards , Risk Factors , Sex Education/methods , Sex Education/standards , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/epidemiology , Sexually Transmitted Diseases/prevention & control , Sexually Transmitted Diseases/psychology , United States/epidemiologyABSTRACT
Native American youth endure a complex interplay of factors that portend greater risk-taking behaviors and contribute to marked health disparities experienced in adolescence. The Asdzáán Be'eená ("Female Pathways" in Navajo) program was developed as a primary prevention program to prevent substance use and teen pregnancy among Navajo girls. The Asdzáán Be'eená program consists of 11 lessons delivered to dyads of girls ages 8 to 11 years and their female caregivers. Feasibility, acceptability, and preliminary impact on risk and protective factors were assessed through a pre-/post study design. Data were collected from girls and their female caregivers at baseline, immediate, and 3 months postprogram completion. Forty-seven dyads enrolled in the study, and 36 completed the 3-month evaluation. At 3 months postprogram, girls reported significant increases in self-esteem, self-efficacy, parent-child relationship, social support, cultural, and sexual health knowledge. Caregivers reported increased family engagement in Navajo culture and parent-child communication and improved child functioning (fewer internalizing and externalizing behaviors). Findings suggest Asdzáán Be'eená has potential to break the cycle of substance use and teen pregnancy in Native communities by improving protective and reducing risk factors associated with these adverse health outcomes. Additional rigorous efficacy trials are necessary to establish program effectiveness.
Subject(s)
Indians, North American , Pregnancy in Adolescence , Preventive Health Services , Substance-Related Disorders , Adolescent , Child , Feasibility Studies , Female , Humans , Indians, North American/education , Parent-Child Relations , Pregnancy , Pregnancy in Adolescence/prevention & control , Preventive Health Services/standards , Preventive Health Services/statistics & numerical data , Program Evaluation , Sexual Behavior , Substance-Related Disorders/prevention & controlABSTRACT
INTRODUCTION: Demands of dialysis regimens may pose challenges for primary care provider (PCP) engagement and timely preventive care. This is especially the case for patients initiating dialysis adjusting to new logistical challenges and management of symptoms and existing comorbid conditions. Since 2011, Medicare has provided coverage for annual wellness visits (AWV), which are primarily conducted by PCPs and may be useful for older adults undergoing dialysis. METHODS: We used the OptumLabs® Data Warehouse to identify a cohort of 1,794 Medicare Advantage (MA) enrollees initiating dialysis in 2014-2017 and examined whether MA enrollees (1) were seen by a PCP during an outpatient visit and (2) received an AWV in the year following dialysis initiation. RESULTS: In the year after initiating dialysis, 93 % of MA enrollees had an outpatient PCP visit but only 24 % received an annual wellness visit. MA enrollees were less likely to see a PCP if they had Charlson comorbidity scores between 0 and 5 than those with scores 6-9 (odds ratio (OR) = 0.59, 95 % CI: 0.37-0.95), but more likely if seen by a nephrologist (OR = 1.60, 95 % CI: 1.01-2.52) or a PCP (OR = 15.65, 95 % CI: 9.26-26.46) prior to initiation. Following dialysis initiation, 24 % of MA enrollees had an AWV. Hispanic MA enrollees were less likely (OR = 0.57, 95 % CI: 0.39-0.84) to have an AWV than White MA enrollees, but enrollees were more likely if they initiated peritoneal dialysis (OR = 1.54, 95 % CI: 1.07-2.23) or had an AWV in the year before dialysis initiation (OR = 4.96, 95 % CI: 3.88-6.34). CONCLUSIONS: AWVs are provided at low rates to MA enrollees initiating dialysis, particularly Hispanic enrollees, and represent a missed opportunity for better care management for patients with ESKD. Increasing patient awareness and provider provision of AWV use among dialysis patients may be needed, to realize better preventive care for dialysis patients.
Subject(s)
Kidney Failure, Chronic/therapy , Medicare , Preventive Health Services/statistics & numerical data , Renal Dialysis , Adolescent , Adult , Aged , Female , Hispanic or Latino , Humans , Male , Middle Aged , Practice Patterns, Physicians' , Preventive Health Services/standards , United States , Young AdultSubject(s)
Anxiety , COVID-19 , Cigarette Smoking , Depression , Minority Health , Preventive Health Services , Smoking , Anxiety/epidemiology , Anxiety/etiology , Anxiety/psychology , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/psychology , Cigarette Smoking/epidemiology , Cigarette Smoking/psychology , Cigarette Smoking/therapy , Depression/epidemiology , Depression/etiology , Depression/psychology , Global Health/trends , Health Services Needs and Demand , Healthcare Disparities , Humans , Minority Health/ethnology , Minority Health/trends , Physical Distancing , Preventive Health Services/methods , Preventive Health Services/standards , SARS-CoV-2 , Smoke-Free Policy , Smoking/epidemiology , Smoking/psychology , Smoking/trends , Smoking Cessation/ethnology , Smoking Cessation/methods , Smoking Prevention , Socioeconomic FactorsSubject(s)
COVID-19 , Osteoporosis , Osteoporotic Fractures , Preventive Health Services/standards , Quality of Life , Risk Adjustment , Aged , Bone Density Conservation Agents/therapeutic use , COVID-19/epidemiology , COVID-19/prevention & control , Female , Health Services Needs and Demand , Humans , Male , Osteoporosis/complications , Osteoporosis/prevention & control , Osteoporotic Fractures/mortality , Osteoporotic Fractures/prevention & control , Osteoporotic Fractures/psychology , Risk Adjustment/methods , Risk Adjustment/standards , Risk Factors , SARS-CoV-2 , Secondary Prevention/methodsABSTRACT
[Figure: see text].
Subject(s)
Antihypertensive Agents/administration & dosage , Hemorrhagic Stroke , Hypertension , Ischemic Stroke , Risk Assessment , Aged , Blood Pressure Determination/methods , Blood Pressure Determination/statistics & numerical data , Female , Heart Disease Risk Factors , Hemorrhagic Stroke/diagnosis , Hemorrhagic Stroke/etiology , Hemorrhagic Stroke/prevention & control , Humans , Hypertension/complications , Hypertension/diagnosis , Hypertension/drug therapy , Hypertension/physiopathology , Ischemic Stroke/diagnosis , Ischemic Stroke/etiology , Ischemic Stroke/prevention & control , Male , Medication Therapy Management/standards , Medication Therapy Management/statistics & numerical data , Middle Aged , Outcome and Process Assessment, Health Care , Patient Care Planning/standards , Preventive Health Services/methods , Preventive Health Services/standards , Risk Assessment/methods , Risk Assessment/statistics & numerical dataABSTRACT
Health maintenance for women of reproductive age includes counseling and screening tests that have been demonstrated to prevent disease and improve health. This article focuses mainly on conditions that are more common in women or have a unique impact on female patients. Family physicians should be familiar with evidence-based recommendations for contraception and preconception care and should consider screening patients for pregnancy intention. The American Academy of Family Physicians recommends against screening pelvic examinations in asymptomatic women; the U.S. Preventive Services Task Force (USPSTF) found insufficient evidence to make a recommendation for or against screening pelvic examinations. The USPSTF recommendations for women in this age group include screening for obesity and other cardiovascular risk factors, depression, intimate partner violence, cervical cancer, HIV, hepatitis C virus, tobacco use, and unhealthy alcohol and drug use as part of routine primary care. Breast cancer screening with mammography is recommended for women 50 years and older and should be individualized for women 40 to 49 years of age, although other organizations recommend earlier screening. Screening for sexually transmitted infections is based on age and risk factors; women younger than 25 years who are sexually active should be screened routinely for gonorrhea and chlamydia, whereas screening for syphilis and hepatitis B virus should be individualized. Immunizations should be recommended according to guidelines from the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices; immunizations against influenza; tetanus; measles, mumps, and rubella; varicella; meningococcus; and human papillomavirus are of particular importance in women of reproductive age. To have the greatest impact on health, physicians should focus on USPSTF grade A and B recommendations with patients.